Investigating the presence of a common drug of abuse (benzhexol) in hair; the Jordanian experience

Journal of Clinical Forensic Medicine

Volumn 9, Issue 3, 2002, Pages 119-125

  Suleiman Al Nsour, Thair ^a   Hadidi, Kamal A ^a  

^a Public Security Directorate   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CANNABIS; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIAMORPHINE; EPHEDRINE; FENETYLLINE; PAPAVERINE; PROCYCLIDINE; TRIHEXYPHENIDYL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG ABUSE; DRUG DETERMINATION; GAS CHROMATOGRAPHY; HAIR ANALYSIS; HUMAN; ION MONITORING; JORDAN; JUVENILE; MALE; MASS SPECTROMETRY; METHODOLOGY; PARKINSON DISEASE; SOLID PHASE EXTRACTION; TOXICOLOGY;

EID: 0036737991     PISSN: 13531131     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-1131(02)00047-0     Document Type: Article

References (31)

1. Reynolds JE. In: Martindale the Extra Pharmacopeia, 29th edn. London: Royal Pharmaceutical Society, 1982; 257-285.
2. Reynolds JE. In: Martindale the Extra Pharmacopeia, 31th edn. London: Royal Pharmaceutical Society, 1993; 421.
3. Koller WC. Disturbance of recent memory function in parkinsonian patients on anticholinergic therapy. Cortx 1984; 20: 307-311.
4. Miller E, Berrios GE, Politynska B. The adverse effect of benzhexol on memory in Parkinson's disease. Acta Neurol Scand 1987; 76: 278-280.
5. Blumensohn R, Razoni G, Shalev A, Munitz H. Bradycardia due to trihexyphenidyl hydrochloride. Drug Intell Clin Pharm 1986; 20: 786-787.
6. Ueno S, Tekahashi M, Kajiyama K, Okahisa N, Hazama T, Yorifuji S, Tarui S. Parkinson's disease and myasthenia gravis: adverse effect of trihexyphenidyl on neuromuscular transmission. Neurology 1987; 37: 832-833.
7. Bachrich PR. New drugs of addiction. Br Med J 1964; 1: 835.
8. Harrison G. The abuse of anti-cholinergic drugs in adolescents. Br J Psychiatr 1980; 137: 495.
9. Lowry TP. Trihexyphenidyl abuse. Am J Psychiatr 1977; 134: 1315.
10. Goggin DA, Solomon GF. Trihexyphenidyl abuse for euphorigenic effect. Am J Psychiatr 1979; 136: 459-460.
11. Macvicar K. Abuse of anti-parkinsonian drugs by psychiatric patient. Am J Psychiatr 1977; 134: 809-811.
12. Cranshaw JA, Mullen PE. A study of benzhexol abuse. Br J Psychiatr 1984; 145: 300-303.
13. Pullen GP, Best NR, Maguire J. Anticholinergic drug abuse: a common problem?. Br Med J 1984; 289: 612-613.
14. Ananth JV, Granshaw JA. Toxic Psychosis induced by benzhexol hydrochloride. Can Med Assoc J 1970; 103: 771-775.
15. Gall JA, Drummer OH, Landgren AJ. Death due to benzhexol toxicity. Forensic Sci Int 1995; 71(1): 9-14.
16. Cheung WK, Stravinski SS, Engel S, Aia LL, Yacobi A, Silber M. Pharmacokinetic evaluation of a sustained-release formulation of trihexypenidyl in healthy volunteers. J Pharmaceut Sci 1988; 77: 748-750.
17. Burke RE, Fahn S. Pharmacokinetic of trihexyphenidyl after short term and long term administration to dystonic patients. Ann Neurol 1985; 18: 35-40.
18. Hadidi KA. Solid-phase extraction of benzhexol from blood and urine. Sci Justice 1997; 37: 265-268.
19. Owen JA, Sribney M, Lawson JS, Delva N, Letemendia FJ. Capillary gas chromatography of trihexyphenidyl [benzhexol hydrochloride], procyclidine [hydrochloride] and cycrimine [hydrochloride] in biological fluids. J Chromatogr 1989; 494: 135-142.
20. Yokogawa K, Nakashima E, Ichimaura F, Yamana T. Simultaneous micro-determination of biperiden, haloperidol and trihexyphenidyl [benzhexol] in plasma and its application to pharmacokinetics analysis after concomitant intravenous administration of the drugs to rabbits. Chem Pharmaceut Bull 1985; 33(10): 4581-4586.
21. Kintz P, Godelar B, Mangin AP, Chaumont AJ. Identification and quantification of triexyphenidyl and its hydroxylated metabolite by gas chromatography with nitroge-phosphorus detection. J Anal Toxicol 1989; 13: 47-49.
22. Scheurer J, Moore CM. Solid phase extraction of drugs from biological tissues-a review. J Anal Toxicol 1992; 16: 264-269.
23. Battah AH, Hadidi KA. Stability of trihexyphenidyl in stored blood and urine specimens. Int J legal Med 1998; 111: 111-114.
24. Gaillard Y, Pepin G. Screening and identification of drugs in human hair by high performance liquid chromatography-photodiode-array UV detection and gas chromatography-mass spectrometry after solid-phase extraction, a powerful tool in forensic medicine. Forensic Sci Int 1997; 84: 37-41.
25. Harkey MR. Anatomy and physiology of hair. Forensic Sci Int 1993; 63: 9-18.
26. Harkey MR, Henderson GL, Zhou C. Simultaneous quantification of cocaine and its major metabolites in human hair by gas chromatography chemical ioinzation mass spectrometry. J Anal Toxicol 1991; 15: 260-266.
27. Skopp G, Potsch L, Moeller MR. On cosmetically treated hair-aspects and pitfalls of interpretation. Forensic Sci Int 1997; 84: 43-52.
28. Dawber R. Hair: its structure and response to cosmetic preparations. Clin Dermatol 1996; 14: 105-112.
29. Jurado C, Kintz P, Menendez M, Repetto M. Influence of cosmetic treatment of hair on drug testing. Inter J Legal Med 1997; 110: 159-163.
30. Blank DL, Kidwell A. Decontamination procedures for drugs of abuse in hair: are they sufficient. Forensic Sci Int 1995; 70: 13-38.
31. Rothe M, Pragst F, Spiegel K, Harrach T, Fischer K, Kunkel J. Hair concentrations and self-reported abuse history of 20 amphetamine and "ecstasy" users. Forensic Sci Int 1997; 89: 111-128.